Buy Insmed Stock | INSM Stock Price & Latest News | Public
INSM

Insmed

$0.00 (0.00%)Today

    About INSM

    Insmed, Inc. is a biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Its first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of My...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.25
    -0.49
    -0.74
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.60

    Actual EPS
    Q3 2020

    Stats

    Market Cap$3,41B
    Volume19,3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$35.32
    1 Year Low$12.09
    Open$33.40
    High$33.84
    Low$32.95

    Buy any stock with any amount of money.

    Download the App
    Download the app